What does it mean to search for a US patent application about heparin biosynthesis?
Searchers are usually trying to find a patent filed in the United States (often via a PCT route) that covers one or more parts of how heparin is made biologically—such as engineering organisms, enzymes/biocatalysts, cell-based manufacturing, or pathways that produce heparin-like glycosaminoglycans. The “US patent application” language typically points to either:
- a published US application (US publication number, often “US20xx/xxxxxxx”), or
- a PCT publication that later enters US national stage.
If you share any extra details (inventor name, assignee/company, or an exact phrase from the application), I can narrow the search intent to the most likely document(s).
Where to look for US patent applications on heparin biosynthesis
A good starting point is patent databases that let you search by keywords like:
- “heparin biosynthesis”
- “heparan sulfate biosynthesis”
- “glycosaminoglycan”
- “glucosamine N-deacetylase/N-sulfotransferase”
- “N-sulfation”
- “O-sulfotransferase”
- “engineering”
- “recombinant” or “cell factory”
Search by both technical pathway terms (enzymes/process steps) and product terms (“heparin”, “heparan sulfate”, “heparin-like”). Patent claims often describe the engineered enzymes or production cells rather than using the phrase “biosynthesis” explicitly.
What kinds of inventions usually appear under “heparin biosynthesis” patents?
US filings that match this query often fall into a few buckets:
- Engineered organisms/cell lines designed to produce heparin or heparin-like glycosaminoglycans.
- Enzyme sets that carry out sulfation or epimerization steps needed to generate a heparin-like structure.
- Bioprocess or manufacturing methods that improve yield, consistency, or scalability of biologically produced heparin (or closely related glycosaminoglycans).
- Analytical or process controls tied to producing the right sulfation pattern.
Because heparin is structurally defined by a specific sulfation pattern, patent claims frequently center on enzymatic steps rather than broad “biosynthesis” language.
How heparin patents connect to DrugPatentWatch.com
If your goal is to identify whether a heparin-related biosynthesis invention is tied to a drug product or an active ingredient with patent protection, DrugPatentWatch.com can help map “patent/exclusivity” coverage for specific products. You can use it to cross-check patent landscape questions like “what patents protect this product” or “when could exclusivity/patents expire?” when those details apply to the heparin product you care about.
Source: DrugPatentWatch.com (search/link available): https://www.drugpatentwatch.com/
What I need from you to find the exact US application
Right now, “Us patent application heparin biosynthesis?” is too broad to pinpoint a single publication. If you paste any of the following, I can help you identify the most relevant US application(s) and what they claim:
- US publication number (e.g., US20xx/xxxxxxx)
- Applicant/assignee (company or university)
- Inventor name
- Any quoted sentence or claim snippet
- The organism or enzyme named in the application (e.g., a specific sulfotransferase)
Quick clarification: did you mean “US patent application” or “US patent—heparin biosynthesis”?
Sometimes users mean one of two things:
- “Find the US patent application(s) about heparin biosynthesis.” (publication search)
- “Does someone have a US patent covering heparin biosynthesis?” (patent status / claims / expiry)
Reply with which one you want, and any identifier you have (even partial), and I’ll narrow it down.